Thrombolex: Funding, Investors & Team (Oct 2026)
Thrombolex specializes in producing and distributing advanced endovascular catheters for treating arterial and venous thromboembolic conditions. Their goal is to create catheters that allow for precise infusion of fluids, including thrombolytics, to effectively treat thrombus in patients' peripheral vasculature. This approach aims to reduce treatment time, lower drug doses, and ultimately decrease costs. Established in 2016, Thrombolex was founded by Michael J. Cerminaro.
Thrombolex has raised $37.6M across 2 funding rounds on record, the most recent an undisclosed round of $32.8M announced in Mar 2026.
That round is above the $4.8M median round size for Health Care companies tracked on FundedIQ over the last two years.
Thrombolex Company Profile and Key Stats
Latest funding round on record: Mar 2026.
Thrombolex Funding Rounds
Thrombolex raised $4.8M in an undisclosed round announced in May 2024.
1.8 years later, an undisclosed round of $32.8M was announced in Mar 2026.
Thrombolex Founders and Leadership Team
Contact details for the Thrombolex team: 1 has a LinkedIn profile.
Start 14-day free trial →Thrombolex Funding Compared to Other Health Care Startups
Thrombolex's latest round of $32.8M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Thrombolex in Health Care and New Britain
Companies Similar to Thrombolex
SedMed provides medical devices that support safer toileting transfers and help prevent falls for individuals…
Aptatek is developing cutting edge technologies for portable disease management devices that will improve…
Flow Medical offers multi-function catheters to aid in the diagnosis and treatment of venous thromboembolic…
Light Wave Dental Management offers management services for high-quality dental offices in Virginia.…
For health care systems and payers focused on improving maternal outcomes and health equity, our product is a…
Tempo Therapeutics creates materials that are designed for regenerative medicine, with a focus on being…
Vibronix was established by Dr. Ji-Xin Cheng and Dr. Pu Wang at Purdue University with the goal of offering…
People with chronic diseases can live their best lives thanks to Vheda Health. We concentrate on three areas…
Thyme Care is an oncology solution that integrates patients and providers, working with health plans to…
https://metriport.com
There are too many reasons why Healthcare is unaffordable in the U.S, but one of the largest is waste. Up to…
Serif Health provides healthcare price intelligence and contract management solution.
Thrombolex Funding FAQs
What does Thrombolex do?
Thrombolex specializes in producing and distributing advanced endovascular catheters for treating arterial and venous thromboembolic conditions. Their goal is to create catheters that allow for precise infusion of fluids, including thrombolytics, to effectively treat thrombus in patients' peripheral vasculature. This approach aims to reduce treatment time, lower drug doses, and ultimately decrease costs. Established in 2016, Thrombolex was founded by Michael J. Cerminaro.
How much funding has Thrombolex raised?
Thrombolex has raised $37.6M across 2 rounds on record. The most recent is an undisclosed round of $32.8M announced in Mar 2026.
When did Thrombolex last raise funding?
Thrombolex's most recent funding round on record is an undisclosed round of $32.8M, announced in Mar 2026.
Who founded Thrombolex?
FundedIQ lists Marvin Woodall (Founder), Michael Cerminaro (Founder) at Thrombolex.
Where is Thrombolex headquartered?
Thrombolex is based in New Britain, Connecticut, United States.
How many employees does Thrombolex have?
Thrombolex is in the 11-50 employee band.
How does Thrombolex's funding compare to other Health Care startups?
Thrombolex's latest round of $32.8M is above the $4.8M median round size for Health Care companies on FundedIQ across 3,657 tracked companies over the last two years.
About FundedIQ's Thrombolex Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Thrombolex is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.